Dr. Taoufik Alsaadi is Chief Medical Officer and Chair of Neurology Department at ACPN. He also serves as an Adjunct Professor of Neurology at Khalifa University, Abu Dhabi. He trained in Epilepsy and Clinical Neurophysiology at the University of California San Francisco and was a research fellow in epilepsy there. He is board-certified by the American Board of Psychiatry and Neurology, the American Board of Clinical Neurophysiology, and the American Board of Neurology in Clinical Epilepsy. He is registered in Abu Dhabi (DOH) and Dubai (DHA) as Consultant Neurologist; and is Aviation Certified Neurologist by the UAE General Civil Aviation Authority (GCAA).
Before joining ACPN, Dr. Alsaadi chaired the Neurology Department at Sheikh Khalifa Medical City for eleven years until 2016. He was Associate Professor of Neurology and Director of the Adult Epilepsy Program and the Clinical Research Program at the University of California Davis, USA for over three years until 2004 when he moved to Abu Dhabi. His work and research focused on conducting drug study trials for new antiepileptic drugs for patients with epilepsy, quality of life in patients with epileptic and non-epileptic disorders, migraine headaches, multiple sclerosis, neuropsychiatric co-morbidities.
Dr. Alsaadi received several honors and awards in recognition of his work in the field of epilepsy. He served on the Advisory Board of the Northern California Epilepsy Foundation and on the membership committee of the American Epilepsy Society. He has previously served as the President of the Western Clinical Neurophysiology Society in the United States and as Vice President of CEMA (Commission of the Eastern Mediterranean Affairs). He is currently the President of the Emirati League Against Epilepsy and Chair of the ILAE Commission for the epilepsy in the elderly. He also serves at the editorial board for BMC Journal of Neurology and Journal of Neurosciences. He has authored and co-authored more than 70 papers and book chapters and has served as a peer-reviewer for more than 15 scientific journals.